Vasamed, Inc.
VSMD · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.40 | -0.03 | -0.08 | 0.05 |
| FCF Yield | -21.25% | -14.65% | -13.44% | -14.53% |
| EV / EBITDA | -10.75 | -11.37 | -8.24 | -8.25 |
| Quality | ||||
| ROIC | 48.98% | 36.32% | 43.60% | 155.51% |
| Gross Margin | 30.36% | 11.32% | 12.16% | 18.08% |
| Cash Conversion Ratio | 0.72 | 0.64 | 1.01 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 21.61% | 9.70% | 3.40% | -13.26% |
| Free Cash Flow Growth | -11.12% | 8.17% | -16.05% | 23.14% |
| Safety | ||||
| Net Debt / EBITDA | -2.99 | -1.55 | 0.23 | -0.02 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.51 | 0.76 | 0.75 | 1.04 |
| Cash Conversion Cycle | 188.12 | 160.51 | 163.10 | 124.97 |